Literature DB >> 350463

Adverse effect of splenectomy in renal transplantation.

G S Rai, R Wilkinson, R M Taylor, P R Uldall, D N Kerr.   

Abstract

Between January 1968 and June 1974 at Newcastle upon Tyne, 63 patients underwent splenectomy in association with transplantation; 45 of these had splenectomy with bilateral nephrectomy before (20) or at the time of (25) transplantation; 18 had post-transplant splenectomy for leucopenia. Mortality was significantly higher in splenectomized patients than in 136 non-splenectomized controls. Of the 63 splenectomized patients, 25 died within 1 year of transplantation, 12 of severe infection associated with leucopenia. Although splenectomy produced a temporary rise in white cell count, leucopenia during the first year of immunosuppressive therapy was not significantly less frequent in splenectomized patients than in controls. There was no significant difference in graft loss between the splenectomy and control groups. It is concluded that splenectomy is contra-indicated in patients who are to undergo renal transplantation and confers no benefit when carried out because of leucopenia developing after renal transplantation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350463

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Partial splenic embolization: experience in 136 patients.

Authors:  O Jonasson; D G Spigos; M F Mozes
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

2.  Cadaver donor renal transplantation by centers of the South-Eastern Organ Procurement Foundation. The prospective study after 6.5 years and 3811 allografts.

Authors:  J C McDonald; W Vaughn; R S Filo; G Mendez-Picon; G Niblack; E K Spees; G M Williams
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

3.  Role of splenectomy in human liver transplantation under modern-day immunosuppression.

Authors:  F Samimi; W D Irish; B Eghtesad; A J Demetris; T E Starzl; J J Fung
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.